Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9892243 | The Journal of Steroid Biochemistry and Molecular Biology | 2005 | 6 Pages |
Abstract
The aim of this study was to analyze the cardiovascular effects of chronic stanozolol administration in male rats. The rats were randomly assigned to one of three groups: (1) control (n = 12), (2) chronic treatment with low dose of stanozolol (LD, n = 18, 5 mg/kg week) and; (3) treatment with high dose of stanozolol (HD, n = 28, 20 mg/kg week). Mean arterial pressure (MAP) was higher in both HD (128 ± 2.2 mmHg) and LD (126 ± 2.5 mmHg) than control (116 ± 2 mmHg). The LD group showed an increase in cardiac output (control 121 ± 2.5, LD 154 ± 5.9 ml/min), whereas in the HD group total peripheral resistance increased (control 1.03 ± 0.07, HD 1.26 ± 0.07 mmHg/ml/min). Acute sympathetic blockade caused a similar decrease in MAP in all groups. In conscious rats, the baroreflex index for bradycardia (control â3.7 ± 0.4, LD â2.0 ± 0.1 beat/mmHg) and tachycardia (control â3.6 ± 0.3, LD â4.7 ± 0.2 beat/mmHg) responses changed only in the LD group. Cardiac hypertrophy was observed in both treated groups (P < 0.05). In conclusion, hypertension with differential hemodynamic changes and alterations in the reflex control in heart rate is seen at different stanozolol doses, which may be important variables in the cardiovascular effects of anabolic steroids.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Abram Beutel, Cássia Toledo Bergamaschi, Ruy Ribeiro Campos,